{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:07:53Z","timestamp":1788732473593,"version":"build-2803163510"},"reference-count":92,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fondation Jean et Linette Warnery"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2020,1,31]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>Rheumatoid arthritis (RA) is associated with a significant disease burden and high costs for society. Because the disease has identifiable preclinical stages, screening and prevention have become a possibility in RA. Anticitrullinated peptide antibodies (ACPAs) are arguably the most likely candidate biomarker to screen for RA. This paper reviews the evidence for the use of ACPAs as a screening test in the broader general population, to identify individuals at high risk of subsequent onset of RA. We will review the diagnostic properties of the test and its positive and negative predictive value in different settings. We will discuss how ACPA testing could effectively be integrated in a broader screening strategy for RA.<\/jats:p>","DOI":"10.1136\/rmdopen-2019-001085","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T04:09:29Z","timestamp":1582171769000},"page":"e001085","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Measuring ACPA in the general population or primary care: is it useful?"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-4347","authenticated-orcid":false,"given":"Axel","family":"Finckh","sequence":"first","affiliation":[{"name":"Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Courvoisier","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Lamacchia","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"2025090312172119000_6.1.e001085.1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/scientificamerican0307-72","article-title":"New predictors of disease","volume":"296","author":"Notkins","year":"2007","journal-title":"Sci Am"},{"key":"2025090312172119000_6.1.e001085.2","unstructured":"Organisation WH . Preventing chronic disease: a vital investment. WHO Press, 2005."},{"key":"2025090312172119000_6.1.e001085.3","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-016-0598-4","article-title":"Preventive treatments for rheumatoid arthritis: issues regarding patient preferences","volume":"18","author":"Finckh","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"2025090312172119000_6.1.e001085.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142109"},{"key":"2025090312172119000_6.1.e001085.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.116020"},{"key":"2025090312172119000_6.1.e001085.6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.berh.2013.09.002","article-title":"Can rheumatoid arthritis be prevented?","volume":"27","author":"Deane","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090312172119000_6.1.e001085.7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.rdc.2014.07.010","article-title":"Prevention of rheumatic diseases: strategies, caveats, and future directions","volume":"40","author":"Finckh","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"2025090312172119000_6.1.e001085.8","doi-asserted-by":"crossref","unstructured":"Al-Laith M , Cope AP . Arthritis prevention in the pre-clinical phase of rheumatoid arthritis with abatacept (APIPPRA). ISRCTN registry 2014.","DOI":"10.1186\/ISRCTN46017566"},{"key":"2025090312172119000_6.1.e001085.9","unstructured":"van Schaardenburg D . Statins to prevent rheumatoid arthritis (STAPRA), 2015. Available: http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=5265 [Accessed 19 Dec 2017]."},{"key":"2025090312172119000_6.1.e001085.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.22525"},{"key":"2025090312172119000_6.1.e001085.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122473"},{"key":"2025090312172119000_6.1.e001085.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.119016"},{"key":"2025090312172119000_6.1.e001085.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105767"},{"key":"2025090312172119000_6.1.e001085.14","unstructured":"Tak P . Prevention of clinically manifest rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease. Nederland trial register 2012 23.08.2010. Available: http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=2442 [Accessed 18 Jul 2012]."},{"key":"2025090312172119000_6.1.e001085.15","unstructured":"Neff T . Rheumatoid arthritis prevention study getting ready to roll. UCHealth insider. Denver: University of Colorado, 2015: 1\u20132."},{"key":"2025090312172119000_6.1.e001085.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212763"},{"key":"2025090312172119000_6.1.e001085.17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s10067-017-3848-6","article-title":"Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies","volume":"36","author":"Einarsson","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025090312172119000_6.1.e001085.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200990"},{"key":"2025090312172119000_6.1.e001085.19","first-page":"281","article-title":"[Principles and practice of mass screening for disease]","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"2025090312172119000_6.1.e001085.20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.073825"},{"key":"2025090312172119000_6.1.e001085.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.24350"},{"key":"2025090312172119000_6.1.e001085.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.20018"},{"key":"2025090312172119000_6.1.e001085.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.11223"},{"key":"2025090312172119000_6.1.e001085.24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/acr.23837","article-title":"Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses\u2019 Health Studies","volume":"71","author":"Liu","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2025090312172119000_6.1.e001085.25","doi-asserted-by":"publisher","DOI":"10.1136\/ard.23.4.302"},{"key":"2025090312172119000_6.1.e001085.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6182.97"},{"key":"2025090312172119000_6.1.e001085.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117969"},{"key":"2025090312172119000_6.1.e001085.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1316"},{"key":"2025090312172119000_6.1.e001085.29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J Immunol"},{"key":"2025090312172119000_6.1.e001085.30","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535790"},{"key":"2025090312172119000_6.1.e001085.31","doi-asserted-by":"publisher","DOI":"10.1186\/ar1149"},{"key":"2025090312172119000_6.1.e001085.32","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044743"},{"key":"2025090312172119000_6.1.e001085.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.37720"},{"key":"2025090312172119000_6.1.e001085.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.013"},{"key":"2025090312172119000_6.1.e001085.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2006.03.008"},{"key":"2025090312172119000_6.1.e001085.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2012.01.008"},{"key":"2025090312172119000_6.1.e001085.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131375"},{"key":"2025090312172119000_6.1.e001085.38","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3"},{"key":"2025090312172119000_6.1.e001085.39","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.035089"},{"key":"2025090312172119000_6.1.e001085.40","doi-asserted-by":"publisher","DOI":"10.1002\/art.24827"},{"key":"2025090312172119000_6.1.e001085.41","first-page":"2535","article-title":"Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis","volume":"30","author":"Saraux","year":"2003","journal-title":"J Rheumatol"},{"key":"2025090312172119000_6.1.e001085.42","doi-asserted-by":"publisher","DOI":"10.1002\/art.38017"},{"key":"2025090312172119000_6.1.e001085.43","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2015.1077461"},{"key":"2025090312172119000_6.1.e001085.44","doi-asserted-by":"publisher","DOI":"10.1002\/art.21575"},{"key":"2025090312172119000_6.1.e001085.45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5114\/ceji.2017.72807","article-title":"The role of anti-citrullinated protein antibodies (AcpA) in the pathogenesis of rheumatoid arthritis","volume":"42","author":"Kurowska","year":"2017","journal-title":"Cejoi"},{"key":"2025090312172119000_6.1.e001085.46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0000000000000356","article-title":"Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis","volume":"29","author":"England","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2025090312172119000_6.1.e001085.47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402334"},{"key":"2025090312172119000_6.1.e001085.48","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204543"},{"key":"2025090312172119000_6.1.e001085.49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","article-title":"Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025090312172119000_6.1.e001085.50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005580","article-title":"Nets are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025090312172119000_6.1.e001085.51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208093"},{"key":"2025090312172119000_6.1.e001085.52","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208094"},{"key":"2025090312172119000_6.1.e001085.53","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215337"},{"key":"2025090312172119000_6.1.e001085.54","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2796-7"},{"key":"2025090312172119000_6.1.e001085.55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11606-010-1540-5","article-title":"Does prevalence matter to physicians in estimating post-test probability of disease? A randomized trial","volume":"26","author":"Agoritsas","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2025090312172119000_6.1.e001085.56","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-146-11-200706050-00011","article-title":"Anti-Cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: Bayes clears the haze","volume":"146","author":"Finckh","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025090312172119000_6.1.e001085.57","doi-asserted-by":"publisher","DOI":"10.1002\/art.22380"},{"key":"2025090312172119000_6.1.e001085.58","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-Analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025090312172119000_6.1.e001085.59","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208980"},{"key":"2025090312172119000_6.1.e001085.60","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jcpe.13117","article-title":"Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis","volume":"46","author":"Loutan","year":"2019","journal-title":"J Clin Periodontol"},{"key":"2025090312172119000_6.1.e001085.61","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5394","article-title":"Prevalence of periodontal disease and periodontopathic bacteria in anti-cyclic citrullinated protein antibody-positive at-risk adults without arthritis","volume":"2","author":"Mankia","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025090312172119000_6.1.e001085.62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00296-014-3083-2","article-title":"Anti-Cyclic citrullinated peptide (CCP) antibody in patients with wood-smoke-induced chronic obstructive pulmonary disease (COPD) without rheumatoid arthritis","volume":"35","author":"Sigari","year":"2015","journal-title":"Rheumatol Int"},{"key":"2025090312172119000_6.1.e001085.63","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-008-8073-2"},{"key":"2025090312172119000_6.1.e001085.64","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209991"},{"key":"2025090312172119000_6.1.e001085.65","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22385"},{"key":"2025090312172119000_6.1.e001085.66","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/rheumatology\/kex239","article-title":"Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis","volume":"56","author":"Alpizar-Rodriguez","year":"2017","journal-title":"Rheumatology"},{"key":"2025090312172119000_6.1.e001085.67","doi-asserted-by":"crossref","unstructured":"Ramos-Remus C , Castillo-Ortiz JD , Aguilar-Lozano L , et al . Autoantibodies in predicting rheumatoid arthritis in healthy relatives of rheumatoid arthritis patients. Arthritis & rheumatology 2015.","DOI":"10.1002\/art.39297"},{"key":"2025090312172119000_6.1.e001085.68","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.40880","article-title":"A prospective study of the development of inflammatory arthritis in the family members of Indigenous North American people with rheumatoid arthritis","volume":"71","author":"Tanner","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090312172119000_6.1.e001085.69","doi-asserted-by":"publisher","DOI":"10.1186\/ar1893"},{"key":"2025090312172119000_6.1.e001085.70","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0800503"},{"key":"2025090312172119000_6.1.e001085.71","doi-asserted-by":"publisher","DOI":"10.1002\/art.27739"},{"key":"2025090312172119000_6.1.e001085.72","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.086314"},{"key":"2025090312172119000_6.1.e001085.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.06.030"},{"key":"2025090312172119000_6.1.e001085.74","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/ijr.14.23","article-title":"The lung may play a role in the pathogenesis of rheumatoid arthritis","volume":"9","author":"Demoruelle","year":"2014","journal-title":"Int J Clin Rheumtol"},{"key":"2025090312172119000_6.1.e001085.75","doi-asserted-by":"crossref","unstructured":"Seror R , Gusto G , Boutron-Ruault MC , et al . Passive smoking in childhood and history of chronic diarrhea increases the risk of developing rheumatoid arthritis (rA). Annals of the Rheumatic Diseases 2017;160.","DOI":"10.1136\/annrheumdis-2017-eular.3853"},{"key":"2025090312172119000_6.1.e001085.76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.rdc.2014.07.007","article-title":"Prediction of future rheumatoid arthritis","volume":"40","author":"Turk","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"2025090312172119000_6.1.e001085.77","doi-asserted-by":"crossref","unstructured":"Lahiri M , Luben RN , Morgan C , et al . Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European prospective investigation of Cancer-Norfolk and the Norfolk arthritis Register-the EPIC-2-NOAR study). AnnRheumDis 2013.","DOI":"10.1136\/annrheumdis-2012-202481"},{"key":"2025090312172119000_6.1.e001085.78","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22005"},{"key":"2025090312172119000_6.1.e001085.79","unstructured":"Sparks JA , Chen CY , Jiang X , et al . Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. Ann Rheum Dis 2014."},{"key":"2025090312172119000_6.1.e001085.80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003808","article-title":"Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking","volume":"9","author":"Scott","year":"2013","journal-title":"PLoS Genet"},{"key":"2025090312172119000_6.1.e001085.81","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202127"},{"key":"2025090312172119000_6.1.e001085.82","unstructured":"Gregersen PK . Translating risk of disease from genetic elements. Washington, DC: American College of Rheumatology Meeting; 2006, 2006."},{"key":"2025090312172119000_6.1.e001085.83","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.040659"},{"key":"2025090312172119000_6.1.e001085.84","doi-asserted-by":"publisher","DOI":"10.1002\/art.27638"},{"key":"2025090312172119000_6.1.e001085.85","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140767"},{"key":"2025090312172119000_6.1.e001085.86","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.053470"},{"key":"2025090312172119000_6.1.e001085.87","doi-asserted-by":"crossref","unstructured":"Boer AC , Wouters F , Dakkak YJ , et al . Improving the feasibility of MRI in clinically suspect arthralgia for prediction of rheumatoid arthritis by omitting scanning of the feet. Rheumatology 2019;72.doi:10.1093\/rheumatology\/kez436","DOI":"10.1093\/rheumatology\/kez436"},{"key":"2025090312172119000_6.1.e001085.88","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000922","article-title":"Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis","volume":"5","author":"Brulhart","year":"2019","journal-title":"RMD Open"},{"key":"2025090312172119000_6.1.e001085.89","unstructured":"Landewe RBM . Response to: 'Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewe. Ann Rheum Dis 2018."},{"key":"2025090312172119000_6.1.e001085.90","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/annrheumdis-2018-213700","article-title":"Overdiagnosis and overtreatment in rheumatology: a little caution is in order","volume":"77","author":"Landewe","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025090312172119000_6.1.e001085.91","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Ten Brinck","year":"2017","journal-title":"Rheumatology"},{"key":"2025090312172119000_6.1.e001085.92","doi-asserted-by":"publisher","DOI":"10.1002\/art.20044"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2019-001085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:17:34Z","timestamp":1756927054000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2019-001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,2,19]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/rmdopen-2019-001085"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2019-001085","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}